Black Technology: Start with Ten Thousand Times Speed

The time slowly came to ten o'clock in the morning.

A handsome and tall figure walked onto the stage and attracted everyone's attention.

Hello everyone, I'm Su Xin.

“Welcome all media friends and guests to Tianqi Medicine’s first press conference.”

Su Xin smiled and said hello to everyone, and then pressed the remote control switch in his hand.

The big screen behind him immediately lit up, displaying the name and logo of Tianqi Pharmaceutical Company.

As everyone knows, I never like to talk nonsense. Let's get straight to the point this time.

The purpose of holding this press conference today is of course to introduce to everyone a new product I have developed. It is also the first blockbuster product of Tianqi Pharmaceutical Company after its establishment.

It's called Tianmu Eye Drops.

The big screen switched, and what appeared in front of everyone was an enlarged version of the reagent bottle picture, with some transparent liquid rippling inside.

This name made everyone immediately understand that the drug developed by Su Xin was related to the eyes.

But what kind of eye disease is it used to treat?

Myopia? glaucoma? blindness?

Thoughts came to everyone's mind.

On stage.

Su Xinxin's PPT showed the shocking numbers that Liu Guosong said at the beginning, allowing everyone to more clearly understand the increasing number and younger trend of myopia, as well as the various social problems caused by it.

Then, he began to explain the principles and functions of Tianmu eye drops in conjunction with PPT.

As we all know, myopia, hyperopia and astigmatism are mainly refractive errors. Taking myopia patients as an example, most people usually wear myopia glasses to correct it.

A small number of people choose surgery, which mainly uses laser surgery to polish the cornea and forcibly change the refractive system through external means to achieve the purpose of correcting myopia.

But everyone should know that this kind of myopia correction surgery not only carries the risk of failure, but also has considerable sequelae.

The Tianmu eye drops I developed are based on biotechnology, using biological agents processed from the metabolites of certain microorganisms to stimulate the eyeballs, and then supplemented with appropriate eye massage, the refractive system can automatically adjust and recover.

Symptoms it can treat include myopia, hyperopia, astigmatism and presbyopia.

“Moreover, it does not require incision, surgery, or any external force to forcibly change the structure of the eyeball. Instead, it achieves the purpose of correcting vision by stimulating the body’s self-regulatory function. There is no pain, no risk, and no Any sequelae.”

Su Xin's words caused everyone to be shocked.

Non-destructive myopia correction sounds like a rather inconspicuous technology. Myopia is not a big deal. Even if most people do not receive treatment, it will not have much impact on their lives.

But.

Considering the exaggerated number and growing trend of myopia patients, the value of this technology is terrible! Even more valuable than many high-sounding technologies! It also makes more sense!

While those pharmaceutical companies were shocked, they were quietly relieved.

Because there are no drugs to treat myopia on the market, the Tianmu eye drops developed by Su Xin do not compete directly with any pharmaceutical company.

However, some senior executives in the eyewear industry who happened to be watching the live broadcast felt a little flustered by the appearance of Tianmu eye drops.

Although the current effectiveness of Tianmu Eye Drops is limited to Su Xin's oral description and has not been tested in clinical trials, Su Xin has such a brilliant past performance that no one dares to underestimate what he said.

And once what Su Xin says is true, it will be a devastating blow to the glasses industry.

No wonder there is an old saying——

It’s not your opponents who defeat you, it’s not your peers who overturn you, it’s the crossover.

Who would have thought that the eyewear industry, with a global market value of trillions, would suddenly face the challenge of a new entrant in the pharmaceutical industry?

Of course, the situation is not that serious at this time, the glasses industry has not yet felt the shock, and many people even know nothing about it.

On stage.

After Su Xin introduced the effects of Tianmu eye drops, he smiled and said:

At present, the approval of this drug has been completed, and clinical trials will begin soon. Starting tomorrow, we will recruit three batches of volunteers on the official website.

At that time, we will announce the progress of all clinical trials, and everyone is welcome to supervise.

After the product introduction, Su Xin introduced Nie Hongwu's identity to everyone, and then left the hosting stage to the latter to speak.

After walking off the stage, Su Xin left the venue in a low-key manner, sent a message to Liu Guosong, and asked him to meet at a teahouse.

…

Half an hour later, in a teahouse private room.

Su Xin and Liu Guosong sat opposite each other.

Taking the initiative to pour Liu Guosong a cup of tea, Su Xin smiled and said:

Uncle, the non-destructive myopia correction technology has been successfully developed. I just don't want to open my own pharmaceutical factory. I wonder if uncle is interested in cooperation?

Liu Guosong smiled: I wish you could do it!

Of course he knew that Su Xin's so-called disinterest was just a polite statement. Faced with a product with unlimited prospects like Tianmu Eye Drops, who would be willing to give up the huge benefits contained in it?

It was only because of Liu Xuewei's face that the other party took the initiative to offer benefits like this.

This made Liu Guosong feel very good, and he was also full of gratitude to Su Xin.

But in fact, what he didn't know was that Su Xin really didn't necessarily care too much about the market prospects of Tianmu Eye Drops, at least not about the profits in the production process.

In Su Xin's view, if such a brand-new pharmaceutical product wants to quickly open up in the market, the easiest way is to cooperate with pharmaceutical companies and provide its own technology, with the latter responsible for production, channel sales and terminal distribution.

You should know that Tianmu eye drops only have a shelf life of two to three months in a laboratory environment. In actual mass production, the shelf life is often shortened when special packaging materials are used.

This places extremely high demands on pharmaceutical companies’ sales channels and terminal distribution.

If Su Xin wants to launch Tianmu eye drops on the market as soon as possible, the best solution is to establish a nationwide sales network.

To achieve this, even if Su Xin has tens of billions of funds and continues to make large-scale acquisitions, it may not be possible in a short time.

so.

The best way is to cooperate with pharmaceutical companies, and to cooperate with multiple pharmaceutical companies at the same time.

Just like other major products such as Thor batteries, it is convenient to develop your own solutions and leave production and sales to partners, which is convenient and can capture the market as quickly as possible.

Now, he just gave one of the cooperation opportunities to Liu Guosong.

In that case, let's arrange for people to connect tomorrow and discuss the details of cooperation.

Okay, I wish us a happy cooperation!

The two of them held their right hands together, and a smile as warm as the spring breeze appeared on their faces.